img

Global Intracranial Therapeutic Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Intracranial Therapeutic Market Research Report 2024

According to MRAResearch’s new survey, global Intracranial Therapeutic market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intracranial Therapeutic market research.
Key companies engaged in the Intracranial Therapeutic industry include Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, Inc., Apic Bio, Stemedica Cell Technologies, Inc., Voyager Therapeutics, Bayer AG and Abeona Therapeutics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Intracranial Therapeutic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intracranial Therapeutic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Intracranial Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis AG
BioMarin
CORESTEM Inc.
Alaunos Therapeutics, Inc.
Apic Bio
Stemedica Cell Technologies, Inc.
Voyager Therapeutics
Bayer AG
Abeona Therapeutics
Spark Therapeutics
Segment by Type
Cell-based Therapy
Gene Therapy
Enzyme Replacement Therapy

Segment by Application


Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Batten Disease
Amyotrophic Lateral Sclerosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Intracranial Therapeutic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intracranial Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cell-based Therapy
1.2.3 Gene Therapy
1.2.4 Enzyme Replacement Therapy
1.3 Market by Application
1.3.1 Global Intracranial Therapeutic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Spinal Muscular Atrophy (SMA)
1.3.3 Multiple Sclerosis
1.3.4 Batten Disease
1.3.5 Amyotrophic Lateral Sclerosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intracranial Therapeutic Market Perspective (2018-2033)
2.2 Intracranial Therapeutic Growth Trends by Region
2.2.1 Global Intracranial Therapeutic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Intracranial Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Intracranial Therapeutic Forecasted Market Size by Region (2024-2033)
2.3 Intracranial Therapeutic Market Dynamics
2.3.1 Intracranial Therapeutic Industry Trends
2.3.2 Intracranial Therapeutic Market Drivers
2.3.3 Intracranial Therapeutic Market Challenges
2.3.4 Intracranial Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intracranial Therapeutic Players by Revenue
3.1.1 Global Top Intracranial Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Intracranial Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Intracranial Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intracranial Therapeutic Revenue
3.4 Global Intracranial Therapeutic Market Concentration Ratio
3.4.1 Global Intracranial Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intracranial Therapeutic Revenue in 2022
3.5 Intracranial Therapeutic Key Players Head office and Area Served
3.6 Key Players Intracranial Therapeutic Product Solution and Service
3.7 Date of Enter into Intracranial Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intracranial Therapeutic Breakdown Data by Type
4.1 Global Intracranial Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Intracranial Therapeutic Forecasted Market Size by Type (2024-2033)
5 Intracranial Therapeutic Breakdown Data by Application
5.1 Global Intracranial Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Intracranial Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Intracranial Therapeutic Market Size (2018-2033)
6.2 North America Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Intracranial Therapeutic Market Size by Country (2018-2023)
6.4 North America Intracranial Therapeutic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intracranial Therapeutic Market Size (2018-2033)
7.2 Europe Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Intracranial Therapeutic Market Size by Country (2018-2023)
7.4 Europe Intracranial Therapeutic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intracranial Therapeutic Market Size (2018-2033)
8.2 Asia-Pacific Intracranial Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Intracranial Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Intracranial Therapeutic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intracranial Therapeutic Market Size (2018-2033)
9.2 Latin America Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Intracranial Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Intracranial Therapeutic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intracranial Therapeutic Market Size (2018-2033)
10.2 Middle East & Africa Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Intracranial Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Intracranial Therapeutic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Intracranial Therapeutic Introduction
11.1.4 Novartis AG Revenue in Intracranial Therapeutic Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Detail
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Intracranial Therapeutic Introduction
11.2.4 BioMarin Revenue in Intracranial Therapeutic Business (2018-2023)
11.2.5 BioMarin Recent Development
11.3 CORESTEM Inc.
11.3.1 CORESTEM Inc. Company Detail
11.3.2 CORESTEM Inc. Business Overview
11.3.3 CORESTEM Inc. Intracranial Therapeutic Introduction
11.3.4 CORESTEM Inc. Revenue in Intracranial Therapeutic Business (2018-2023)
11.3.5 CORESTEM Inc. Recent Development
11.4 Alaunos Therapeutics, Inc.
11.4.1 Alaunos Therapeutics, Inc. Company Detail
11.4.2 Alaunos Therapeutics, Inc. Business Overview
11.4.3 Alaunos Therapeutics, Inc. Intracranial Therapeutic Introduction
11.4.4 Alaunos Therapeutics, Inc. Revenue in Intracranial Therapeutic Business (2018-2023)
11.4.5 Alaunos Therapeutics, Inc. Recent Development
11.5 Apic Bio
11.5.1 Apic Bio Company Detail
11.5.2 Apic Bio Business Overview
11.5.3 Apic Bio Intracranial Therapeutic Introduction
11.5.4 Apic Bio Revenue in Intracranial Therapeutic Business (2018-2023)
11.5.5 Apic Bio Recent Development
11.6 Stemedica Cell Technologies, Inc.
11.6.1 Stemedica Cell Technologies, Inc. Company Detail
11.6.2 Stemedica Cell Technologies, Inc. Business Overview
11.6.3 Stemedica Cell Technologies, Inc. Intracranial Therapeutic Introduction
11.6.4 Stemedica Cell Technologies, Inc. Revenue in Intracranial Therapeutic Business (2018-2023)
11.6.5 Stemedica Cell Technologies, Inc. Recent Development
11.7 Voyager Therapeutics
11.7.1 Voyager Therapeutics Company Detail
11.7.2 Voyager Therapeutics Business Overview
11.7.3 Voyager Therapeutics Intracranial Therapeutic Introduction
11.7.4 Voyager Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023)
11.7.5 Voyager Therapeutics Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Detail
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Intracranial Therapeutic Introduction
11.8.4 Bayer AG Revenue in Intracranial Therapeutic Business (2018-2023)
11.8.5 Bayer AG Recent Development
11.9 Abeona Therapeutics
11.9.1 Abeona Therapeutics Company Detail
11.9.2 Abeona Therapeutics Business Overview
11.9.3 Abeona Therapeutics Intracranial Therapeutic Introduction
11.9.4 Abeona Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023)
11.9.5 Abeona Therapeutics Recent Development
11.10 Spark Therapeutics
11.10.1 Spark Therapeutics Company Detail
11.10.2 Spark Therapeutics Business Overview
11.10.3 Spark Therapeutics Intracranial Therapeutic Introduction
11.10.4 Spark Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023)
11.10.5 Spark Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Intracranial Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cell-based Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Enzyme Replacement Therapy
Table 5. Global Intracranial Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Intracranial Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Intracranial Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Intracranial Therapeutic Market Share by Region (2018-2023)
Table 9. Global Intracranial Therapeutic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Intracranial Therapeutic Market Share by Region (2024-2033)
Table 11. Intracranial Therapeutic Market Trends
Table 12. Intracranial Therapeutic Market Drivers
Table 13. Intracranial Therapeutic Market Challenges
Table 14. Intracranial Therapeutic Market Restraints
Table 15. Global Intracranial Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Intracranial Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Intracranial Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Therapeutic as of 2022)
Table 18. Ranking of Global Top Intracranial Therapeutic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Intracranial Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Intracranial Therapeutic Product Solution and Service
Table 22. Date of Enter into Intracranial Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Intracranial Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Intracranial Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Intracranial Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Intracranial Therapeutic Revenue Market Share by Type (2024-2033)
Table 28. Global Intracranial Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Intracranial Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Intracranial Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Intracranial Therapeutic Revenue Market Share by Application (2024-2033)
Table 32. North America Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Intracranial Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Intracranial Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Intracranial Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Intracranial Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Intracranial Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Intracranial Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Intracranial Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Intracranial Therapeutic Product
Table 50. Novartis AG Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. BioMarin Company Detail
Table 53. BioMarin Business Overview
Table 54. BioMarin Intracranial Therapeutic Product
Table 55. BioMarin Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 56. BioMarin Recent Development
Table 57. CORESTEM Inc. Company Detail
Table 58. CORESTEM Inc. Business Overview
Table 59. CORESTEM Inc. Intracranial Therapeutic Product
Table 60. CORESTEM Inc. Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 61. CORESTEM Inc. Recent Development
Table 62. Alaunos Therapeutics, Inc. Company Detail
Table 63. Alaunos Therapeutics, Inc. Business Overview
Table 64. Alaunos Therapeutics, Inc. Intracranial Therapeutic Product
Table 65. Alaunos Therapeutics, Inc. Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 66. Alaunos Therapeutics, Inc. Recent Development
Table 67. Apic Bio Company Detail
Table 68. Apic Bio Business Overview
Table 69. Apic Bio Intracranial Therapeutic Product
Table 70. Apic Bio Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 71. Apic Bio Recent Development
Table 72. Stemedica Cell Technologies, Inc. Company Detail
Table 73. Stemedica Cell Technologies, Inc. Business Overview
Table 74. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Product
Table 75. Stemedica Cell Technologies, Inc. Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Stemedica Cell Technologies, Inc. Recent Development
Table 77. Voyager Therapeutics Company Detail
Table 78. Voyager Therapeutics Business Overview
Table 79. Voyager Therapeutics Intracranial Therapeutic Product
Table 80. Voyager Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 81. Voyager Therapeutics Recent Development
Table 82. Bayer AG Company Detail
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Intracranial Therapeutic Product
Table 85. Bayer AG Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 86. Bayer AG Recent Development
Table 87. Abeona Therapeutics Company Detail
Table 88. Abeona Therapeutics Business Overview
Table 89. Abeona Therapeutics Intracranial Therapeutic Product
Table 90. Abeona Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 91. Abeona Therapeutics Recent Development
Table 92. Spark Therapeutics Company Detail
Table 93. Spark Therapeutics Business Overview
Table 94. Spark Therapeutics Intracranial Therapeutic Product
Table 95. Spark Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 96. Spark Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intracranial Therapeutic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Intracranial Therapeutic Market Share by Type: 2022 VS 2033
Figure 3. Cell-based Therapy Features
Figure 4. Gene Therapy Features
Figure 5. Enzyme Replacement Therapy Features
Figure 6. Global Intracranial Therapeutic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Intracranial Therapeutic Market Share by Application: 2022 VS 2033
Figure 8. Spinal Muscular Atrophy (SMA) Case Studies
Figure 9. Multiple Sclerosis Case Studies
Figure 10. Batten Disease Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Case Studies
Figure 12. Intracranial Therapeutic Report Years Considered
Figure 13. Global Intracranial Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Intracranial Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Intracranial Therapeutic Market Share by Region: 2022 VS 2033
Figure 16. Global Intracranial Therapeutic Market Share by Players in 2022
Figure 17. Global Top Intracranial Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Therapeutic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Intracranial Therapeutic Revenue in 2022
Figure 19. North America Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Intracranial Therapeutic Market Share by Country (2018-2033)
Figure 21. United States Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Intracranial Therapeutic Market Share by Country (2018-2033)
Figure 25. Germany Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Intracranial Therapeutic Market Share by Region (2018-2033)
Figure 33. China Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Intracranial Therapeutic Market Share by Country (2018-2033)
Figure 41. Mexico Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Intracranial Therapeutic Market Share by Country (2018-2033)
Figure 45. Turkey Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Intracranial Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Novartis AG Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 48. BioMarin Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 49. CORESTEM Inc. Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 50. Alaunos Therapeutics, Inc. Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 51. Apic Bio Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 52. Stemedica Cell Technologies, Inc. Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 53. Voyager Therapeutics Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 54. Bayer AG Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 55. Abeona Therapeutics Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 56. Spark Therapeutics Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed